A Private Equity firm with multiple offices throughout the US is currently making investments out of its latest fund of over $700M. The firm looks to make multi-stage investments ranging from $20-$50 million. The firm is willing to review opportunities from around the Globe with a heavy emphasis on North America.
The firm is currently interested broadly in the healthcare space including Medical Technology, Therapeutics, Diagnostics, Laboratory Equipment, Healthcare IT and R&D services. For medical technology the firm is looking for companies that have at least an alpha prototype and have some efficacy data. For companies working with therapeutics the firm is looking for assets that are in Phase II of clinical trials and will only consider companies in Phase I if they have efficacy data. The firm generally does not look for companies in the cardiovascular space and they are open to orphan indications. The firm is also open to investing in companies that have products already on the market.
The firm looks for a strong management team to be in place and is open to invest in both private and publicly held companies. For companies that are privately held the firm generally looks to take a board seat.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment